Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents
International Journal of Molecular Sciences · 14.05.2026 · 27 (10) · 4385
DOI: 10.3390/ijms27104385 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2026. Verfasst von Mukanda Gedeon Kadima und 10 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban 4000, South Africa. Hauptthemen laut MEDLINE: Isoniazid, Antitubercular Agents, Mycobacterium tuberculosis, Pyrazoles. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, NRF-SA.
Abstract (Originalsprache)
A series of INH–pyrazole molecular hybrids (6a–o) was synthesized and evaluated for in vitro anti-tubercular activity against drug-susceptible, multidrug-resistant (MDR), and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains, alongside their corresponding precursors (4a–o), using isoniazid (INH) as the reference drug. Overall, the hybrid compounds exhibited inhibitory activity comparable to or exceeding that of INH against the drug-susceptible strain. Among the series, compounds 6a, 6d–6f, and 6m demonstrated the highest potency, with a minimum inhibitory concentration (MIC) of 0.9 µM, corresponding to an approximately 4.3-fold enhancement relative to INH. Compounds 6b,c, 6g–i, and 6l,m also showed noticeable activity (MIC = 1.95 µM), representing an approximate twofold improvement over INH and significantly outperforming their respective precursors. Notably, compound 6o exhibited enhanced activity against the XDR strain (MIC = 121 µM), reflecting an approximately 2.8-fold improvement compared to precursor 4o (MIC > 341 µM), thereby highlighting the advantage of molecular hybridization. However, all compounds displayed diminished activity relative to INH against the resistant strains. Against the MDR strain, compounds 4h, 6e, and 6g displayed measurable activity, with MIC values of 76, 125, and 112 µM, respectively. Cytotoxicity assessment using THP-1 human monocytic cells revealed low toxicity, with all tested compounds maintaining acceptable cell viability at 10 µg/mL. In addition, in silico ADME analysis indicated that the hybrid molecules comply with key drug-likeness criteria. Collectively, these findings suggest that INH–pyrazole hybrids represent promising lead scaffolds for the development of next-generation anti-tubercular agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discipline of Pharmaceutical Sciences, Westville Campus, University of KwaZulu-Natal, Durban 4000, South Africa.
- Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Rondebosch, Cape Town 7701, South Africa.
- Discipline of Chemistry, Westville Campus, University of KwaZulu-Natal, P/Bag X54001, Durban 4000, South Africa.
- National Health Laboratory Services (NHLS), Department of Microbiology, Inkosi Albert Luthuli Central Hospital, Durban 4000, South Africa.
- Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, 1919 Route de Mende, 34293 Montpellier, France.
- INSERM, IRIM, 34293 Montpellier, France.
ORCID-Profile: Mukanda Gedeon Kadima, Vinayak Singh, Sahil Mishra, Pule Seboletswe, Ankit, Françoise Roquet-Banères, Laurent Kremer, Rajshekhar Karpoormath, Parvesh Singh
Förderung
- National Research Foundation
- NRF-SA
Zitieren
APA
Kadima, M. G., Singh, V., Kumar, G., Mishra, S., Seboletswe, P., Ankit, Kajee, A., Roquet-Banères, F., Kremer, L., Karpoormath, R., & Singh, P. (2026). Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents. International Journal of Molecular Sciences, 27(10), 4385. https://doi.org/10.3390/ijms27104385
Vancouver
Kadima MG, Singh V, Kumar G, Mishra S, Seboletswe P, Ankit, et al. Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents. International Journal of Molecular Sciences. 2026;27(10):4385. doi:10.3390/ijms27104385
BibTeX
@article{Kadima2026,
author = {Kadima, Mukanda Gedeon and Singh, Vinayak and Kumar, Gobind and Mishra, Sahil and Seboletswe, Pule and Ankit and Kajee, Afsana and Roquet-Banères, Françoise and Kremer, Laurent and Karpoormath, Rajshekhar and Singh, Parvesh},
title = {Development of Isoniazid–Pyrazole Hybrids as Potential Antitubercular Agents},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4385},
doi = {10.3390/ijms27104385}
}
EUVIMED